Jackson Denise L

SEC source: 0001320242-26-000002 · wk-form4_1779144694.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,835

F1 · kind: Shares were acquired pursuant to a grant of restricted stock units (RSUs) under the Tractor Supply Company 2018 Stock Incentive Plan. Each RSU entitles the reporting person to receive one share of common stock. The RSUs vest one year from the date of the grant.

F1 · acquired: Shares were acquired pursuant to a grant of restricted stock units (RSUs) under the Tractor Supply Company 2018 Stock Incentive Plan. Each RSU entitles the reporting person to receive one share of common stock. The RSUs vest one year from the date of the grant.

SEC source: 0000916365-25-000137 · wk-form4_1753390119.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,123

F1 · kind: The reported stock sale was effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on February 14, 2025.

SEC source: 0000916365-25-000133 · wk-form4_1752528652.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,288

F1 · kind: The reported stock sale was effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on February 14, 2025.

SEC source: 0000916365-25-000133 · wk-form4_1752528652.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,288

F1 · kind: The reported stock sale was effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on February 14, 2025.

SEC source: 0000916365-25-000131 · wk-form4_1752267100.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,288

F1 · kind: The reported stock sale was effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on February 14, 2025.

SEC source: 0000916365-25-000129 · wk-form4_1752095610.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,288

F1 · kind: The reported stock sale was effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on February 14, 2025.

SEC source: 0000916365-25-000129 · wk-form4_1752095610.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 37,288

F1 · kind: The reported stock sale was effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on February 14, 2025.

SEC source: 0000916365-25-000129 · wk-form4_1752095610.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,918

F1 · kind: The reported stock sale was effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on February 14, 2025.

SEC source: 0000916365-25-000125 · wk-form4_1751922617.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,918

F1 · kind: The reported stock sale was effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on February 14, 2025.

SEC source: 0000916365-25-000106 · wk-form4_1747429005.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,468

F1 · kind: Shares were acquired pursuant to a grant of restricted stock units (RSUs) under the Tractor Supply Company 2018 Stock Incentive Plan. Each RSU entitles the reporting person to receive one share of common stock. The RSUs vest one year from the date of the grant.

F1 · acquired: Shares were acquired pursuant to a grant of restricted stock units (RSUs) under the Tractor Supply Company 2018 Stock Incentive Plan. Each RSU entitles the reporting person to receive one share of common stock. The RSUs vest one year from the date of the grant.

F2 · balance_after: This balance has been adjusted to reflect the 5-for-1 stock split effective December 20, 2024.

SEC source: 0000916365-24-000067 · wk-form4_1715371625.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,651

F1 · kind: Shares were acquired pursuant to a grant of restricted stock units (RSUs) under the Tractor Supply Company 2018 Stock Incentive Plan. Each RSU entitles the reporting person to receive one share of common stock. The RSUs vest one year from the date of the grant.

F1 · acquired: Shares were acquired pursuant to a grant of restricted stock units (RSUs) under the Tractor Supply Company 2018 Stock Incentive Plan. Each RSU entitles the reporting person to receive one share of common stock. The RSUs vest one year from the date of the grant.

SEC source: 0001209191-23-046580 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,648

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-046580 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,693

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on August 15, 2021. The number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of August 15, 2021 comparing the average closing price for the 90-day period prior to August 15, 2021 to the period prior to August 15, 2023 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on August 16, 2023. The Company's Relative TSR measured in the 75th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-23-029228 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,318

F1 · kind: The reporting person transferred 200 shares of AMN Common Stock as a gift to charity.

SEC source: 0000916365-23-000066 · wf-form4_168392508818262.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,031

F1 · kind: Shares were acquired pursuant to a grant of restricted stock units (RSUs) under the Tractor Supply Company 2018 Stock Incentive Plan. Each RSU entitles the reporting person to receive one share of common stock. The RSUs vest one year from the date of the grant.

F1 · acquired: Shares were acquired pursuant to a grant of restricted stock units (RSUs) under the Tractor Supply Company 2018 Stock Incentive Plan. Each RSU entitles the reporting person to receive one share of common stock. The RSUs vest one year from the date of the grant.

SEC source: 0001209191-23-010857 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,253

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-010857 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,880

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 6, 2020. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, annual year-over-year performance targets based, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") over a three-year period beginning on January 1, 2020 and ended December 31, 2022. As a result, 171% of the target amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-23-003818 · doc4.xml · derivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,706

Underlying: Common Stock · 3,706 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-23-003818 · doc4.xml · derivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,381

Underlying: Common Stock · 1,172 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-23-003818 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,565

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-003818 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,909

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-23-013321 · doc4a.xml · derivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,706

Underlying: Common Stock · 3,706 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date

SEC source: 0001209191-23-013321 · doc4a.xml · derivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,381

Underlying: Common Stock · 1,172 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date

SEC source: 0001209191-23-013321 · doc4a.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,562

F3 · kind: Number of shares withheld for tax purposes.

F2 · balance_after: Due to an administrative error, the Form 4 filed by the reporting person on January 18, 2023 overstated the amount of securities beneficially owned following the reported transactions by 5,003 shares. This Form 4 is being amended and restated to reflect that, following the reported transactions, 14,906 and 14,562 securities were beneficially owned by reporting person, not 19,909 and 19,565, respectively, that were previously reported. The administrative error was carried forward to the Form 4 filed on February 17, 2023.

SEC source: 0001209191-23-013321 · doc4a.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,906

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

F2 · balance_after: Due to an administrative error, the Form 4 filed by the reporting person on January 18, 2023 overstated the amount of securities beneficially owned following the reported transactions by 5,003 shares. This Form 4 is being amended and restated to reflect that, following the reported transactions, 14,906 and 14,562 securities were beneficially owned by reporting person, not 19,909 and 19,565, respectively, that were previously reported. The administrative error was carried forward to the Form 4 filed on February 17, 2023.

SEC source: 0001209191-23-021672 · doc4a.xml · derivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,706

Underlying: Common Stock · 3,706 shares

Expires not disclosed

F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date

SEC source: 0001209191-23-021672 · doc4a.xml · derivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,381

Underlying: Common Stock · 1,172 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date

SEC source: 0001209191-23-021672 · doc4a.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,830

F3 · kind: Number of shares withheld for tax purposes.

F2 · balance_after: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 344 shares due to an administrative error. The same error occurred in the Reporting Person's Form 4s filed January 10, 2023 and January 6, 2023. The Form 4 filed on January 10, 2023 understated the Restricted Stock Units acquired by 370 shares, and the Form 4 filed on January 6, 2023 understated the Restricted Stock Units acquired by 530 shares and the Performance Restricted Stock Units acquired by 1,289 shares. The error flowed through to the reported amount of securities beneficially owned by the Reporting Person in the Form 4 filed February 17, 2023. Following the transaction on February 17, 2023, the Reporting Person held 17,518 shares of common stock. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction.

SEC source: 0001209191-23-021672 · doc4a.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,174

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

F2 · shares: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 344 shares due to an administrative error. The same error occurred in the Reporting Person's Form 4s filed January 10, 2023 and January 6, 2023. The Form 4 filed on January 10, 2023 understated the Restricted Stock Units acquired by 370 shares, and the Form 4 filed on January 6, 2023 understated the Restricted Stock Units acquired by 530 shares and the Performance Restricted Stock Units acquired by 1,289 shares. The error flowed through to the reported amount of securities beneficially owned by the Reporting Person in the Form 4 filed February 17, 2023. Following the transaction on February 17, 2023, the Reporting Person held 17,518 shares of common stock. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction.

F2 · balance_after: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 344 shares due to an administrative error. The same error occurred in the Reporting Person's Form 4s filed January 10, 2023 and January 6, 2023. The Form 4 filed on January 10, 2023 understated the Restricted Stock Units acquired by 370 shares, and the Form 4 filed on January 6, 2023 understated the Restricted Stock Units acquired by 530 shares and the Performance Restricted Stock Units acquired by 1,289 shares. The error flowed through to the reported amount of securities beneficially owned by the Reporting Person in the Form 4 filed February 17, 2023. Following the transaction on February 17, 2023, the Reporting Person held 17,518 shares of common stock. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction.

SEC source: 0001209191-23-002801 · doc4.xml · nonDerivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,078

F5 · kind: The sale of 4,001 shares of AMN Common Stock was affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F6 · price: The price reported in this row represents a weighted average price of $110.76 per share. These shares were sold in multiple transactions at prices ranging from $110.41 to $111.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-23-002801 · doc4.xml · derivative · entry 5

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,259 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F8 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 6, 2020 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F9 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-23-002801 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,079

F3 · kind: The sale of 1,002 shares of AMN Common Stock was affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The price reported in this row represents a weighted average price of $109.30 per share. These shares were sold in multiple transactions at prices ranging from $109.30 to $109.31, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-23-002801 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,081

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-002801 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,451

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-23-002396 · doc4.xml · derivative · entry 5

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,579

Underlying: Common Stock · 1,532 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-23-002396 · doc4.xml · nonDerivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,562

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-002396 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,851

F3 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 6, 2020. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2019 for the 3-year period beginning on January 1, 2020 and ended December 31, 2022 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2023. The Company's Relative TSR measured in the 89th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-23-002396 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,739

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-23-002396 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,269

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units.

SEC source: 0001209191-22-056224 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,267

F1 · kind: Reflects the gift of common stock to a charitable donor advised fund.

SEC source: 0001209191-22-048050 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,267

F1 · kind: The sale of 6,330 shares of Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $107.09 per share. These shares were sold in multiple transactions at prices ranging from $106.59 to $107.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-046755 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,597

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-22-046755 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,642

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on August 15, 2021. The number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of August 15, 2021 comparing the average closing price for the 90-day period prior to August 15, 2021 to the period prior to August 15, 2022 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on August 16, 2022. The Company's Relative TSR measured in the 86th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0000916365-22-000067 · wf-form4_165230197255765.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,379

F1 · kind: Shares were acquired pursuant to a grant of restricted stock units (RSUs) under the Tractor Supply Company 2018 Stock Incentive Plan. Each RSU entitles the reporting person to receive one share of common stock. The RSUs vest one year from the date of the grant.

F1 · acquired: Shares were acquired pursuant to a grant of restricted stock units (RSUs) under the Tractor Supply Company 2018 Stock Incentive Plan. Each RSU entitles the reporting person to receive one share of common stock. The RSUs vest one year from the date of the grant.

SEC source: 0001209191-23-021671 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,002

F1 · date: Filed late due to administrative error.

F2 · kind: The sale of 4,515 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in this row represents a weighted average price of $109.26 per share. These shares were sold in multiple transactions at prices ranging from $109.17 to $109.62, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F4 · balance_after: Due to the late filing, the amount of securities beneficially owned by the reporting person following the reported transactions in subsequently filed Form 4s have been overstated.

SEC source: 0001209191-22-011922 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,267

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-22-011922 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,866

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 3, 2019. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization, divided by gross revenue and expressed as a percentage ("Adjusted EBITDA Margin") as of December 31, 2021 for the one-year period beginning on January 1, 2021 and ended December 31, 2021. As a result, 200% of the target amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-22-003903 · doc4.xml · derivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,553

Underlying: Common Stock · 3,553 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F2 · derivative.exercise_date: The Restricted Stock Units set forth in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second, and third anniversaries of the grant date.

F3 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.

SEC source: 0001209191-22-002782 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,752

F1 · kind: The sale of 796 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in this row represents a weighted average price of $118.4865 per share. These shares were sold in multiple transactions at prices ranging from $118.225 to $118.545, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-22-002611 · doc4.xml · derivative · entry 5

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,259

Underlying: Common Stock · 1,221 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F8 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 6, 2020 and vest on the first, second and third anniversaries of the grant date.

F9 · derivative.expiration_date: Restricted Stock Units do not have an expiration date.